These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11669404)

  • 1. The effects of streptokinase and hydroxyethyl starch on in vitro clot disruption by ultrasound.
    Adler Y; Attar D; Vaturi M; Golovchiner G; Iakobishvili Z; Battler A; Siegel RJ; Birnbaum Y
    Cardiovasc Drugs Ther; 2001 Mar; 15(2):119-23. PubMed ID: 11669404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of low-frequency ultrasound-induced clot disruption by hydroxyethyl starch is dependent on the duration and intensity of ultrasound exposure; an in vitro study.
    Adler Y; Dagan A; Golovchiner G; Iakobishvili Z; Matz I; Lev E; Siegel RJ; Birnbaum Y
    Ultrasound Med Biol; 2003 Mar; 29(3):483-6. PubMed ID: 12706200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. There is synergism between high-intensity, low-frequency ultrasound and streptokinase but not with eptifibatide, heparin, and aspirin. Differential effects on fresh and aged blood clots. An in vitro study.
    Wyshelesky A; Iakobishvili Z; Matz I; Golovchiner G; Vaturi M; Siegel RJ; Birnbaum Y
    Thromb Res; 2001 Aug; 103(4):337-44. PubMed ID: 11562343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution.
    Birnbaum Y; Atar S; Luo H; Nagai T; Siegel RJ
    Thromb Res; 1999 Dec; 96(6):451-8. PubMed ID: 10632468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro ultrasound augmented clot dissolution--what is the optimal timing of ultrasound application?
    Shlamovitz GZ; Iakobishvili Z; Matz I; Golovchiner G; Lev E; Siegel RJ; Birnbaum Y
    Cardiovasc Drugs Ther; 2002 Dec; 16(6):521-6. PubMed ID: 12766386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microparticle-containing oncotic solutions augment in-vitro clot disruption by ultrasound.
    Birnbaum Y; Iakobishvili Z; Porter A; Hasdai D; Atar S; Siegel RJ; Battler A
    Thromb Res; 2000 Jun; 98(6):549-57. PubMed ID: 10899354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone.
    Härdig BM; Carlson J; Roijer A
    BMC Cardiovasc Disord; 2008 Aug; 8():19. PubMed ID: 18727834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of in vitro hemodilution with hydroxyethyl starch and dextran on the activity of plasma clotting factors.
    Petroianu GA; Maleck WH; Koetter KP; Liu J; Schmitt A
    Crit Care Med; 2003 Jan; 31(1):250-4. PubMed ID: 12545024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs.
    Atar S; Luo H; Birnbaum Y; Nagai T; Siegel RJ
    J Thromb Thrombolysis; 2001 May; 11(3):223-8. PubMed ID: 11577261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.
    Marsh JN; Senpan A; Hu G; Scott MJ; Gaffney PJ; Wickline SA; Lanza GM
    Nanomedicine (Lond); 2007 Aug; 2(4):533-43. PubMed ID: 17716136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of potato starch derived and corn starch derived hydroxyethyl starch on in vitro blood coagulation.
    Jamnicki M; Zollinger A; Seifert B; Popovic D; Pasch T; Spahn DR
    Anaesthesia; 1998 Jul; 53(7):638-44. PubMed ID: 9771171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT.
    Konrad CJ; Markl TJ; Schuepfer GK; Schmeck J; Gerber HR
    Anesth Analg; 2000 Feb; 90(2):274-9. PubMed ID: 10648306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the in vitro effects of saline, hypertonic hydroxyethyl starch, hypertonic saline, and two forms of hydroxyethyl starch on whole blood coagulation and platelet function in dogs.
    Wurlod VA; Howard J; Francey T; Schweighauser A; Adamik KN
    J Vet Emerg Crit Care (San Antonio); 2015; 25(4):474-87. PubMed ID: 26037241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of acute progressive normovolemic hemodilution with lactated Ringer's, gelatin and hydroxyethyl starch on coagulation and survival rate in rabbits].
    Li LY; Xu X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 40(3):292-300. PubMed ID: 18560458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography.
    Jamnicki M; Zollinger A; Seifert B; Popovic D; Pasch T; Spahn DR
    Anesth Analg; 1998 Nov; 87(5):989-93. PubMed ID: 9806670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro- and antifibrinolytic effects of ultrasound on streptokinase-induced thrombolysis.
    Nilsson AM; Odselius R; Roijer A; Olsson SB
    Ultrasound Med Biol; 1995; 21(6):833-40. PubMed ID: 8571471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5.
    Langeron O; Doelberg M; Ang ET; Bonnet F; Capdevila X; Coriat P
    Anesth Analg; 2001 Apr; 92(4):855-62. PubMed ID: 11273914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation.
    Schaden E; Wetzel L; Kozek-Langenecker S; Thaler U; Scharbert G
    Br J Anaesth; 2012 Oct; 109(4):572-7. PubMed ID: 22791802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysis.
    Strauss RG; Stump DC; Henriksen RA; Saunders R
    Transfusion; 1985; 25(3):230-4. PubMed ID: 2408362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro comparison of the effects of voluven (6% hydroxyethyl starch 130/0.4) and hespan (6% hydroxyethyl starch 670/0.75) on measures of blood coagulation in canine blood.
    Griego-Valles M; Buriko Y; Prittie JE; Fox PR
    J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):44-51. PubMed ID: 27712013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.